NWBO & Pfizer: Secret London Boardroom Holds the Key to a Billion-Dollar Biotech Mystery
Jake Phillips | London Bureau
London. Midnight. A sealed acquisition proposal sits between two pharmaceutical negotiating teams. The price is enormous. One director refuses to sign.
What happens when the boardroom doors reopen? Details remain closely guarded. Check back for the next dispatch.
Continue Your Research
Browse the Stock Ratings Directory
Explore Buyout Watch
Visit the Trading Academy
Browse Biotech Catalyst Watch
Browse OTC Buzz Tracker